Gene: ZDHHC11
Official Full Name: zDHHC palmitoyltransferase 11provided by HGNC
Gene Summary: Enables signaling adaptor activity. Involved in antiviral innate immune response and positive regulation of defense response to virus by host. Located in endoplasmic reticulum. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO00047 | ZDHHC11 Knockout cell line (PC9-OR1) | Human | ZDHHC11 | 1:2-1:4 | Negative | Online Inquiry |
KO12428 | ZDHHC11 Knockout cell line (HeLa) | Human | ZDHHC11 | 1:3~1:6 | Negative | Online Inquiry |
KO12429 | ZDHHC11 Knockout cell line (HCT 116) | Human | ZDHHC11 | 1:2~1:4 | Negative | Online Inquiry |
KO12430 | ZDHHC11 Knockout cell line (HEK293) | Human | ZDHHC11 | 1:3~1:6 | Negative | Online Inquiry |
KO12431 | ZDHHC11 Knockout cell line (A549) | Human | ZDHHC11 | 1:3~1:4 | Negative | Online Inquiry |
ZDHHC11 Gene Knockout Cell Lines are genetically engineered cell lines designed to specifically disrupt the ZDHHC11 gene, which encodes a member of the zinc finger DHHC-type palmitoyltransferase family. These unique cell lines facilitate the study of palmitoylation—a pivotal post-translational modification that influences protein stability, localization, and function—by enabling researchers to assess the functional consequences of ZDHHC11 gene deletion.
The key function of these knockout cell lines lies in their capacity to provide insights into the biological roles of ZDHHC11 and its associated substrates. Through gene knockout methodologies, such as CRISPR/Cas9 technology, these cell lines effectively eliminate ZDHHC11 expression, allowing scientists to analyze alterations in cellular processes, including signal transduction pathways and lipid metabolism. This mechanism substantially enhances the understanding of how perturbations in palmitoylation can contribute to various disease states, including neurodegenerative disorders and cancer.
From a scientific standpoint, ZDHHC11 Gene Knockout Cell Lines are invaluable in both research and clinical applications. In research settings, they serve as a powerful tool for investigating the molecular mechanisms underlying cellular signaling and metabolic pathways. Clinically, the knowledge gained from studies utilizing these cell lines could lead to the development of targeted therapies aimed at modulating palmitoylation in disease contexts.
Compared to conventional wild-type cell lines, the ZDHHC11 knockout variants present a distinct advantage by allowing for specific examinations of gene function and protein interactions. This specificity equips researchers with clearer insights that would be obscured in heterogenous cell populations, enhancing the discovery process and facilitating the translation of findings into therapeutic interventions.
For researchers, clinicians, and biotech professionals seeking to delve deeper into the functional genomics of palmitoylation, the ZDHHC11 Gene Knockout Cell Lines provide a unique and robust platform. Our company possesses extensive expertise in genetic engineering and cell line development, ensuring that our product exemplifies the highest standards of quality and applicability in advancing biological research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.